Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Mar
1
2024
Gold Dome Report - Crossover Day Wrap-Up Nelson Mullins
Sep
14
2023
Stark Integrity Podcast: FCA, CARES Act, and Call Arrangements Episodes [Podcast] Nelson Mullins
Sep
21
2021
Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated “Breakthrough Devices” Nelson Mullins
Oct
11
2021
HHS Rescinds Rule to Provide Insulin and Injectable Epinephrine at 340B Prices Nelson Mullins
Aug
15
2023
FDA Finalizes Informed Consent Guidance for Drug and Medical Device Clinical Investigations Nelson Mullins
Oct
3
2022
FDA Concludes Software Pre-Cert Pilot Program, Noting Federal Legislative Action is Needed Nelson Mullins
Feb
20
2023
Old North State Report – Feb. 20, 2023 Nelson Mullins
Jun
9
2023
Old North State Report – June 5, 2023 Nelson Mullins
Jul
18
2023
Hospital Price Transparency Changes in the Calendar Year 2024 Hospital Outpatient Prospective Payment System Proposed Rule Nelson Mullins
Sep
22
2021
Ushering in a New Era of OTC Drug Regulation, FDA Posts First Batch of “Deemed” Final Administrative Orders Nelson Mullins
Oct
26
2021
FDA Convenes Medical Device Workshop Focused on Artificial Intelligence and Machine Learning Transparency Nelson Mullins
Sep
24
2022
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP U.S. Customs and Border Protection
Jan
7
2023
CBP Officers at the San Ysidro Port of Entry Seize Over $2 Million Worth of Cocaine U.S. Customs and Border Protection
Nov
7
2022
CBP Officers Seize $18.6 Million in Methamphetamine at Laredo Port of Entry U.S. Customs and Border Protection
Oct
24
2021
CBP Issues Withhold Release Order on Tomatoes Produced by Farm in Mexico U.S. Customs and Border Protection
Oct
31
2019
Legal Pot = Manufacturing Storm Clouds (the Refrain) Robinson & Cole LLP
Mar
16
2023
As COVID-19 Emergency Waivers End, DEA Proposes to Expand Tele-Prescribing of Controlled Substances Robinson & Cole LLP
Nov
5
2020
ShopRite Settles with NJ AG for Data Breach Robinson & Cole LLP
Apr
17
2024
Weight Loss, Miracle Medications & the Workplace Robinson & Cole LLP
May
6
2021
Girl Scout Troop Teams Up with Wing for Drone Cookie Deliveries Robinson & Cole LLP
Apr
4
2019
Medical Marijuana Delivery App Agrees to Settle TCPA Case for $1.75M Robinson & Cole LLP
Oct
25
2022
Advisory Opinion 22-19: OIG Warns That Proposed Drug Cost Subsidization Arrangement May Warrant Sanctions Robinson & Cole LLP
Jan
28
2020
DOJ Reaches Settlement with Patient Assistance Foundation Resolving Allegations of FCA Violations Robinson & Cole LLP
May
8
2020
Connecticut Governor Ned Lamont Issues Executive Order Allowing Pharmacists to Order COVID-19 Tests Robinson & Cole LLP
Oct
21
2021
EPA Releases PFAS Strategic Roadmap - October 21, 2021 Robinson & Cole LLP
Jan
31
2019
OIG Advisory Opinion No. 19-02 Allows Pharmaceutical Manufacturer to Temporarily Loan Smartphones to Financially Needy Patients to Receive Data from a Digestible Medication Sensor Robinson & Cole LLP
May
25
2022
Connecticut Makes Significant Changes to its Collaborative Drug Therapy Laws Robinson & Cole LLP
Jul
12
2019
Connecticut Legislature Modifies Statutes Relevant to Preventing and Treating Opioid Use Disorder Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins